• 1. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 2. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 3. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 4. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 5. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615

Introduction to 2-Bromo-6-fluoro-3-methylbenzoic acid (CAS No. 1359857-60-5)

2-Bromo-6-fluoro-3-methylbenzoic acid, identified by the Chemical Abstracts Service Number (CAS No.) 1359857-60-5, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and medicinal chemistry. This benzoic acid derivative, characterized by its bromine and fluorine substituents, along with a methyl group, exhibits unique structural and chemical properties that make it a valuable intermediate in the synthesis of various bioactive molecules.

The compound’s molecular structure consists of a benzoic acid core, which is a well-known scaffold in drug design, modified by three key substituents: a bromine atom at the 2-position, a fluorine atom at the 6-position, and a methyl group at the 3-position. These substituents not only influence the electronic properties of the molecule but also play a crucial role in its interactions with biological targets. The presence of halogen atoms, particularly bromine and fluorine, is particularly noteworthy as they are frequently employed in medicinal chemistry to enhance metabolic stability, binding affinity, and overall pharmacological activity.

In recent years, 2-bromo-6-fluoro-3-methylbenzoic acid has been explored as a building block in the development of novel therapeutic agents. Its structural features make it a promising candidate for further derivatization to create compounds with targeted biological effects. For instance, the bromine atom can serve as a handle for cross-coupling reactions, such as Suzuki or Buchwald-Hartwig couplings, which are widely used in constructing complex organic molecules. Similarly, the fluorine atom can modulate the pharmacokinetic properties of derived compounds, potentially improving their bioavailability and duration of action.

One of the most compelling aspects of 2-bromo-6-fluoro-3-methylbenzoic acid is its utility in the synthesis of small-molecule inhibitors targeting various disease-related pathways. Current research indicates that this compound and its derivatives may have applications in oncology, inflammation, and infectious diseases. For example, studies have demonstrated that benzoic acid derivatives can interfere with key enzymatic processes involved in cancer cell proliferation. The specific arrangement of substituents in 2-bromo-6-fluoro-3-methylbenzoic acid may enhance its ability to bind to these enzymes with high selectivity and potency.

The fluorine atom at the 6-position is particularly interesting from a medicinal chemistry perspective. Fluorinated aromatic compounds are known for their ability to improve drug-like properties such as lipophilicity and metabolic stability. In particular, C-F bonds are often more stable than C-H bonds due to their higher bond dissociation energy, which can contribute to increased resistance against degradation by metabolic enzymes. This characteristic makes 2-bromo-6-fluoro-3-methylbenzoic acid an attractive starting point for designing long-acting drugs that require multiple dosing intervals.

Furthermore, the bromine atom at the 2-position provides another layer of functionalization potential. Bromine is frequently used in medicinal chemistry to introduce reactive sites for further chemical transformations or to serve as a bioisostere for other halogen atoms. For instance, brominated benzoic acids can be converted into amides or esters through nucleophilic aromatic substitution reactions, expanding their utility in drug discovery campaigns.

Recent advances in computational chemistry have also highlighted the importance of 2-bromo-6-fluoro-3-methylbenzoic acid as a scaffold for virtual screening and de novo design. Molecular modeling studies suggest that this compound can be optimized to target specific protein receptors or enzymes with high affinity. By leveraging computational tools, researchers can predict how different substitutions or modifications will affect the biological activity of derived compounds, thereby accelerating the drug discovery process.

The synthesis of 2-bromo-6-fluoro-3-methylbenzoic acid itself is another area of interest. While detailed synthetic routes are not within the scope of this discussion, it is worth noting that benzoic acid derivatives are typically synthesized through multi-step processes involving functional group transformations such as halogenation, alkylation, and carboxylation. The availability of high-quality starting materials like 2-bromo-6-fluoro-3-methylbenzoic acid (CAS No. 1359857-60-5) simplifies many synthetic challenges and allows researchers to focus on downstream applications rather than basic synthetic methodology.

In conclusion,2-Bromo-6-fluoro-3-methylbenzoic acid represents a versatile and promising compound in pharmaceutical research. Its unique structural features offer numerous opportunities for further chemical manipulation and biological evaluation. As our understanding of disease mechanisms continues to evolve, compounds like this one will play an increasingly important role in developing innovative therapeutic strategies across multiple therapeutic areas.

• 2252-37-1(2-Bromo-6-fluorobenzoic acid)
• 415965-24-1(4-Bromo-2-fluoro-5-methylbenzoic acid)
• 183065-69-2(2,4-Dibromo-6-fluorobenzoic acid)
• 183065-72-7(6-Bromo-2,3-difluorobenzoic acid)
• 1003709-39-4(2-bromo-5-fluoro-4-methylbenzoic acid)
• 820236-81-5(Methyl 2-bromo-6-fluorobenzoate)
• 1245807-64-0(2-Bromo-5-fluoroterephthalic acid)
• 1214352-42-7(3,6-Dibromo-2-fluorobenzoic acid)
• 124244-65-1(2-Bromo-3,6-difluorobenzoic acid)
• 651026-99-2(2-Bromo-4,6-difluorobenzoic acid)